Questions discussed in this category
Is this acute or long-term, and does it matter whether this is SBRT vs fractionated?
Normally, waiting 6-12 weeks of therapeutic anticoagulation after an acute PE is suggested for any bronchoscopic procedure, however there is always a ...
Patient became acutely flushed, developed severe and prolonged hypotension with brief loss of consciousness, dizziness, nausea, dry heaves and headach...
Specifically in O2-dependent patients? Have any dose/fractionation regimens been shown to reduce the risk of pneumonitis in this population?
Do you typically push for myocardial biopsy in this case?
Does active smoking status influence this decision?
The cohort in the study was predominantly white. Do these results highlight significant disparities in COPD care?
If so, would this be a consideration in all patients regardless of active smoking status? FeNO in active smokers has been questioned, could this have ...
While classically described as seen in seropositive patients, have they been reported in seronegative RA?
In the span between the Hypothermia After Cardiac Arrest Trial (HACA, 2002) and the Targeted Temperature Management in Out-of-Hospital Cardiac Arrest ...
Given the suggestion of the antagonistic effect of azithromycin on IV tobramycin in prior studies.
Do you favor awake intubation in these cases?
Patients on baseline mycophenolate and azathioprine were excluded from the INBUILD trial however many patients with CTD-ILD will be on some form of im...
What factors do you consider while deciding between bronchoscopic vs surgical management?
What’s your threshold to get the three AFBs and place the patient in airborne isolation?
What is your preferred anticoagulation in patients with BMI >50?
To help interpret clinical applications of the CAPE COD (2023) and DEXA ARDS (2020) trials.
Do you base the decision on FEV1, 6MWD or symptoms at initial evaluation, or progression over time?
Are there any quantitative indices (eg. volume, pleural fluid hematocrit) that would impact your decision to stop subsequent TPA/dornase treatments?
When adding nintedanib what sort of treatment course do you counsel the patient on? Do you plan to continue it indefinitely as long as the patient tol...
Do you prefer to start with nintedanib and then add immunosuppressive agents, or give a trial of immunosuppressive medication first, then add nintedan...
Do you do start therapy at a certain vasopressor requirement?
Is there a minimum standard for which stations to sample? Does lymph node size affect your recommendations?
How do you decide between starting infliximab, MMF, or IVIG? If a patient presents in respiratory failure (nearing or requiring intubation), woul...
Is there any role of tube thoracostomy as opposed to only antibiotics?
Do your respiratory therapists independently adjust ventilator settings without direct physician involvement?
How do you approach which risk to accept given that steroids have evidence for use in COVID-19 while is suggestion for harm in using steroids in influ...
For instance, if the patient doesn’t tolerate apnea testing, is too unstable to go for ancillary testing outside the ICU, and TCDs/EEG are unava...
Do you use hydrocortisone 200 mg/day as studied in ADRENAL/APROCCHSS or dexamethasone 20 mg/day as studied in DEXA-ARDS?
Are patients with long standing malignant central airway obstruction poor candidates for central airway stents? What is considered to be an acceptable...
Given the substantial risks associated with transporting an intubated and ventilated patient to Radiation Oncology, is there any evidence to support t...
Does your management change if symptomatic or asymptomatic?
Would you obtain baseline PFT on all patients or only selected high risk patients? Would you repeat PFTs regularly or only if clinically symptomatic?&...
(Normal oxygenation and echo)
Apart from removing the latex balloon, do you employ any additional technical accommodations?
If a patient clearly has N1 disease with high SUV on PET, do you routinely recommend EBUS or mediastinoscopy to evaluate for N2 disease?
Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?
Is there a difference in monitoring frequency for legacy drugs like bosentan vs newer agents (macitentan, ambrisentan)?
Occasionally, supplemental oxygen may alter Fick measurements giving falsely high CO and falsely low PVR, therefore is Thermodilution method preferred...
I've seen a handful of fatal radiation pneumonitis associated with rapid steroid tapers by the non-treating physicians. How do you recommend prescribi...
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice?
Assuming other non CTD related causes for PAH have been excluded
Are there situations in which you would recommend dilation of stenotic airways after radiation? Is there a concern for increased complications of dila...
Clinical trial NCT02181257 to explore this currently in process
How are your teams effectively evaluating and counseling patients to ensure they are prepared for potential extended adjuvant treatment approaches? Is...
Would you suggest switching to a viral vector vaccine, such as J&J?
Would you consider the immune suppressed status of the patient as a high risk factor to offer adjuvant therapy?
Can patients be re-challenged after developing ILD? Is the toxicity seen with T-Dxd a potential barrier to use?
Do you feel the dosing used in...
Would you discontinue Methotrexate and TNF inhibitors even if previously no side effects from these medications, and would you consider Cyclophosphami...
Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?
Are two negative pleurocentesis' adequate to conclude that the patient does not have metastatic disease? Do you routinely recommend VATS and pleural b...
Do you use imaging (fibrosis vs. pneumonitis), PFTs, duration of prior immunosuppressive therapy?
Would you change rituximab maintenance dose or schedule?
Would you consider treating the full mediastinum or any mildly enlarged nodes, even contralateral? Do you have a strategy that transitions from a pall...
Would inhaled steroids help reduce the PO dose and/or significantly accelerate tapering? If s, for what pneumonitis grade? What specific steroid...
Should patient be considered for definitive therapy or chemo alone if pleural cytology positive but no T4, N2, or sarcomatoid features?
How is your approach to treatment different than other ILD patterns such as NSIP? Does treatment response vary based on underlying CTD?
Cyclophosphamide/tacrolimus and Rituximab have been used in conjunction with steroids in case series.
For example, a patient with a large (>3cm), spiculated, FDG-avid lung lesion, who has poor lung function and is refusing a CT-guided biopsy?
Does the type of cardiac involvement impact this choice?
If so, what would be an ideal DMARD in this setting?
For T2bN0 or T3N0 disease, you consider radiation alone, sequential radiation followed by chemotherapy, or concurrent chemoradiation?
After initiation of anti-TB treatment and 3 negative AFB smears, would you initiate concurrent chemoRT? Would you give sequential RT then chemo to giv...
This question is part of a collaboration with RheumMadness and is in reference to: Pathogenic ANCARAVE Trial
Would your practice change if the patient had N2 disease?
If you use both, how do you decide which to use for a particular patient?
The SENSCIS trial was published in 2019 on efficacy of this agent. However, it's not clear where this should be in the treatment algorithm: Monot...
I’ve noticed some patients develop worsening SOB and DOE months after RT and rather than interstitial diffuse pattern you would see with pneumon...
Any differences in the risks between SBRT vs. conventionally fractionation? Concurrent immunotherapy?
Is there a certain age beyond which it is not safe to do SBRT?
Should staging and treatment decisions be made based on imaging alone?
Would you treat with chemotherapy (carboplatin/etoposide) vs anti-pd-1 monotherapy vs combination chemoimmunotherapy vs supportive care?
Does the degree of PD-L1 expression weigh into your decision?
Do you recommend or make any modifications in the PACIFIC regimen for patients > 75 years of age?
Is IO related pneumonitis in the radiation field or more diffuse?
If clinically node negative, would you add elective nodal radiation?Does it depend on location (upper vs. lower trachea)?
Does it factor into your decision making in the setting of restricted spirometry and normal lung volumes? Does this differ for SBRT v. chemoRT?
Would you treat if there is active infection? How much improvement would you expect?
Are you using ctDNA blood tests for targetable mutations at the time of diagnosis, at the time of disease progression, or not at all?
When there is biopsy proven mediastinal disease, do you offer definitive chemoradiation and monitor, or do you try to prove the presence/absence ...
Do you incoprate Ki67% or mitotic rate into your treatment decision, and is there any use for somatostatin based imaging such as octreoscan or gallium...
Is there any role for consolidative RT/CRT to the lung and mediastinum after initial chemo? What dose and fractionation would be most appropriate for ...
There are varying reports in the literature which seem to suggest increased rates of Gr 4-5 pneumonitis in IPF patients. How do you manage these...
What about patients who are still on steroids for radiation pneumonitis?
The NCCN guidelines call for pathological mediastinal lymph node staging for all NSCLC except in solid tumors <1cm and non-solid lesions < ...
Following lung RT, I have rarely seen patients present with pneumonia-like symptoms of radiation pneumonitis. I'm more likely to see a patient with wo...
Is there any concern about hemorrhage from treatment effect on tumor? Would SABR worsen the chance of fatal hemorrhage/hemoptysis and if so, would you...
Roughly what percentage of patients are treated without a biopsy?
In practice, do you send patients with N2/3 disease for mediastinal staging if not offered upfront?
1622918156176911810115058175841792217388126131469517807178901765317855360317712177351773617737177381652314451128861101397041764016343175811765513660164611300412704170191759916992160871345415722175441744973251735116985171611716012664158181698316882154071662916627126271624316839168111684216626167701294516705164341431214325160771659316009125141655013819153001649416453165011645016509164511608896671319616056162451613616230144831431316024127831252115929228815783124961420215819158011565415530157312540502812510149841557512991125201218113613153861409715177154521500215054151461522812515151381381814988141831491114916125081375214427125117725132925158146281375114568144791448414409144301440012518125161251210011125021266913507140141249412857134071350313738429213488129941350113678136611357413629134991347713437134431249213096129491277212500132061310313077131021250713012125061277112774126011272012670124951268612497124991252612498126211249312509125131250512490125561250411448121581209911736117501116711148107882741104329678105011043510275102671021897549970998798649700954895589364938382229003909990858903900088868885862788055910851685567314847383558118651278917931796779667637732176637313732071157318693672257091681657285507511150714920465443562640126523032053190316751438973933625529313
Papers discussed in this category
Radiother Oncol, 2011 Nov
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-10-20
J Thorac Cardiovasc Surg, 2011 Mar
Semin Radiat Oncol, 2015 Oct
J. Clin. Oncol., 2008-07-20
Chest, 2007 Sep
JCO Precision Oncology, 2017 Sep 29
Sci Rep, 2014 Sep 09
Medicine (Baltimore),
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-10-01
Lung cancer (Amsterdam, Netherlands), 1994-03
Clin Lung Cancer, 2017 Jul 10
J Thorac Oncol,
Clinical lung cancer, 2018-07
Int. J. Radiat. Oncol. Biol. Phys., 2017 Mar 15
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016-06
Journal of vascular and interventional radiology : JVIR, 2021 Mar 31
Int. J. Radiat. Oncol. Biol. Phys., 2010-06-01
Thorac Cancer, 2017 Apr 24
International journal of radiation oncology, biology, physics, 2013-03-01
Respir. Res., 2018 Apr 24
Radiographics : a review publication of the Radiological Society of North America, Inc, 2004
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-03
The New England journal of medicine, 2015-07-16
N Engl J Med, 2017 Nov 16
The New England journal of medicine, 2018-12-06
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-01-10
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014-04
Clinical lung cancer, 2017-07
Int. J. Radiat. Oncol. Biol. Phys., 2020 Feb 07
Cureus, 2019 Jun 22
Lung Cancer, 2009 Jan 24
Radiat Oncol, 2016 Dec 03
Adv Radiat Oncol, 2020 May 05
Cancer Discov, 2020 May 01
Lancet, 2020 May 28
Int. J. Radiat. Oncol. Biol. Phys., 2020 Apr 14
The New England journal of medicine, 2010-07-15
Medicine (Baltimore),
The New England journal of medicine, 2010-07-15
N. Engl. J. Med., 2019 May 20
The Lancet. Respiratory medicine, 2016-09
The New England journal of medicine, 2006-06-22
J Thorac Oncol, 2020 Feb 24
Cancer Treat Rev, 2022 Mar 12
Archives of internal medicine, 2008-09-22
Arthritis and rheumatism, 2010-06
Ann. Rheum. Dis., 2018 Apr 25
Ann. Rheum. Dis., 2017 May 25
Ann. Rheum. Dis., 2018 May 03
Chest, 2007-07
Radiat Oncol, 2016 Apr 18
Journal of the National Cancer Institute, 2011-10-05
BMC Cancer, 2018 Oct 12
Semin Arthritis Rheum, 2020 Jun
Intern Med, 2014 Dec 01
J Am Heart Assoc, 2019 Sep 06
Clin Rheumatol, 2007 Mar 30
The New England journal of medicine, 2017-05-18
Kidney international reports, 2018-03
N Engl J Med, 2020 Feb 13
Rheumatology (Oxford),
Lancet Respir Med, 2020 Aug 28
N Engl J Med,
Nature reviews. Rheumatology, 2018-05
Trials, 2017 Jun 15
N Engl J Med, 2019 Sep 29
Arthritis Rheumatol, 2021 Feb 03
N Engl J Med, 2012 May 20
Journal of thoracic disease, 2013-12
Thorac Surg Clin, 2020 Sep 12
Sleep Med Rev, 2021 Jun 10
J Heart Lung Transplant, 2021 Nov
Interact Cardiovasc Thorac Surg, 2015 Jan 07
Rheumatology (Oxford, England), 2011 Dec 30
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010-02
International journal of radiation oncology, biology, physics, 1980-08
Journal for immunotherapy of cancer, 2017-11-21
J Immunother Cancer, 2021 Feb
J Natl Compr Canc Netw,
Ann Oncol,
J Immunother Cancer,
J Immunother Cancer,
J Clin Oncol, 2021 Dec 20
J Natl Compr Canc Netw,
Ann Intern Med,
Ann Rheum Dis, 2011 Nov 29
Respir Med, 2012 Apr 09
Am J Respir Crit Care Med,
Arthritis Rheum,
Eur Heart J, 2015 Aug 29
Eur Respir J, 2019 Jan 24
BMJ Open, 2019 May 05
Rheumatol Int, 2021 Jan 29
N Engl J Med, 2020 Sep 19
J Clin Oncol, 2021 Nov 02
The European respiratory journal, 2014-11
Clin Exp Rheumatol, 2019 Nov 20
N Engl J Med,
Lung, 2021 Apr 07
RMD Open, 2021 Sep
JAMA,
Eur Respir Rev, 2021 Dec 15
Ann Am Thorac Soc,
Ann Am Thorac Soc,
American journal of respiratory and critical care medicine, 2010-08-01
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2002-10
Eur Respir J,
Eur Respir J,
J Intern Med,
Drugs,
Eur Respir J, 2021 Dec 16
N Engl J Med, 2021 Jan 13
Lancet Respir Med, 2021 Jun 29
Radiology, 2012-10
The New England journal of medicine, 2014-04-10
The American journal of cardiology, 2016-11-15
J Bronchology Interv Pulmonol, 2021 Nov 10
Crit Care, 2021 Jul 28
N Engl J Med, 2022 Sep 04
Chest, 2015-09
J Thorac Dis,
Eur Respir J, 2013 Oct 31
Am J Respir Crit Care Med,
The European respiratory journal, 2015-10
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000-04
Chest, 2018 Jan 11
J Allergy Clin Immunol Pract, 2021 Mar 06
Chest, 2020 Aug 31
J Allergy Clin Immunol Pract, 2020 Jun 16
Cureus, 2020 Aug 12
J Allergy Clin Immunol Pract, 2015 Jan 29
The European respiratory journal, 2019-01
Eur Respir J, 2019 Jan 24
Chest, 2021 Feb
Chest, 2011-06
JAMA,
JAMA,
Circulation, 2001-01-02
The European respiratory journal, 2019-05
Interv Cardiol Clin,
Circ Cardiovasc Qual Outcomes,
Eur Respir J, 2017 Jun 08
Ann Am Thorac Soc,
American journal of respiratory and critical care medicine, 2011-02-15
Chest, 2011-07
The Lancet. Respiratory medicine, 2017-12
ERJ Open Res, 2019 Jul 08
BMC Pulm Med, 2018 Jan 17
American journal of respiratory and critical care medicine, 2013-04-01
Am J Respir Crit Care Med,
The European respiratory journal, 2018-08
J Am Coll Cardiol,
N Engl J Med, 2022 Jun 03
J Clin Oncol, 2022 Jun 03
Rheumatology (Oxford, England), 2017-06-01
Autoimmun Rev, 2012 Jul 05
The Lancet. Respiratory medicine, 2018-08
Respir Med, 2011 Sep 13
Mayo Clin Proc, 2018 May 24
Respirology, 2021 Oct 06
JAMA,
Ann Intern Med, 2020 Sep 08
Arthritis & rheumatology (Hoboken, N.J.), 2017-03
Lancet Respir Med, 2021 Jan
American journal of respiratory and critical care medicine, 2018-11-01
Ann Am Thorac Soc,
Chest,
Chest, 1997-01
Pulm Circ, 2021 Jun 14
Am J Respir Crit Care Med,
Annals of the American Thoracic Society, 2015-05
Int J Chron Obstruct Pulmon Dis, 2020 Jun 09
Am J Respir Crit Care Med,
Cochrane Database Syst Rev, 2021 Mar 26
Lupus, 2020 Feb 09
N Engl J Med,
BMC Res Notes, 2020 Aug 03
Respirology, 2022 Apr 19
Lancet Respir Med,
Eur Respir Rev, 2022 Apr 13
Future Sci OA, 2020 Aug 03
Cancer Treat Res Commun, 2022 Jul 01
Trends Immunol, 2021 Mar 10
Journal of the American College of Cardiology, 2018-09-25
Blood Adv,
CMAJ,
JAMA cardiology, 2016-09-01
Chest, 2020 Aug 14
Chest, 2020 Jul
ERJ Open Res, 2020 Oct
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2022 Jun 11
European respiratory review : an official journal of the European Respiratory Society, 2021 Dec 22
Eur Respir J, 2019 Apr 18
Am J Obstet Gynecol MFM, 2021 Mar 27
Respirology, 2013 Nov 29
Respir Res, 2022 Jun 21
J Thorac Oncol, 2013 Nov
Practical radiation oncology, 2011
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017-01
N Engl J Med, 2019 Oct 31
J Cyst Fibros, 2020 Jul 18
Circulation, 2013-07-30
The European respiratory journal, 2018-02
Circulation, 2011 Jun 27
Int J Cardiol, 2019 Jan 04
Cochrane Database Syst Rev, 2019 Jan 31
Chest, 2014 Nov
Circulation, 2021 Feb 08
N Engl J Med, 2021 Aug 27
ERJ Open Res, 2022 Feb 21
AACE Clin Case Rep, 2020 Aug 06
Am J Med, 1987 Jun
Sarcoidosis Vasc Diffuse Lung Dis, 2012 Mar
Arch Osteoporos, 2017 Jul 19
BMJ Case Rep, 2022 Jul 08
Arthritis Res Ther, 2014 Mar 24
J Infect Dis, 2020 Jun 11
Clin Chest Med, 2013 Apr 08
Chest, 2016-03
Chest, 2008 Feb 08
JAMA, 2010 Nov 24
Eur Respir J, 2017 Sep 09
Thorax, 2019 Jan
Clin Med Insights Circ Respir Pulm Med, 2021 Mar 30
Cureus, 2022 Sep 06
Respir Res, 2023 Jan 9
The New England journal of medicine, 2002-02-21
N Engl J Med, 2013 Nov 17
Cureus, 2022 Sep 11
Crit Care, 2020 Jan 06
JAMA, 2005-10-05
Trials, 2016 Jul 22
N Engl J Med, 2023 Mar 21
J Thromb Haemost, 2021 Jul 14
Blood, 2020 Mar 19
JAMA, 2019-10-01
Chest, 2020 Aug 11
Ann Am Thorac Soc, 2017 May
Respiratory medicine, 2016-12
Thorax, 2021 Oct 27
Journal of clinical medicine, 2020 Dec 23
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014-06
Blood, 2015 Apr 27
Transplantation, 2021 Jul 01
The American journal of gastroenterology, 2003 Jun
The Journal of rheumatology, 2015 Jun 15
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014-04-18
Heart rhythm, 2014-07
Circulation journal : official journal of the Japanese Circulation Society, 2019 Oct 09
Acta oncologica (Stockholm, Sweden), 2019 Jul 18